Matsushima-Nishiwaki R, Yamada N, Hattori Y, Hosokawa Y, et al. SERMs (selective estrogen receptor modulator), acting as estrogen receptor beta agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-alpha-induced migration via specific inhibition of AKT signaling pathway. PLoS One 2022;17:e0262485.
PMID: 35007301